186 related articles for article (PubMed ID: 14598962)
1. Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi.
Harries AD; Nyirenda TE; Kemp JR; Squire BS; Godfrey-Faussett P; Salaniponi FM
Int J Tuberc Lung Dis; 2003 Nov; 7(11):1040-4. PubMed ID: 14598962
[TBL] [Abstract][Full Text] [Related]
2. Characteristics, management and outcome of patients with recurrent tuberculosis under routine programme conditions in Malawi.
Salaniponi FM; Nyirenda TE; Kemp JR; Squire SB; Godfrey-Faussett P; Harries AD
Int J Tuberc Lung Dis; 2003 Oct; 7(10):948-52. PubMed ID: 14552564
[TBL] [Abstract][Full Text] [Related]
3. When are follow-up sputum smears actually examined in patients treated for new smear-positive pulmonary tuberculosis?
Harries AD; Gausi F; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Apr; 8(4):440-4. PubMed ID: 15141736
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
5. Decentralisation of treatment for patients with tuberculosis in Malawi: moving from research to policy and practice.
Salaniponi FM; Gausi F; Mphasa N; Nyirenda TE; Kwanjana JH; Harries AD
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S38-47. PubMed ID: 12971653
[TBL] [Abstract][Full Text] [Related]
6. Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India.
Santha T; Thomas A; Chandrasekaran V; Selvakumar N; Gopi PG; Subramani R; Rajeswari R; Rani B; Paramasivan CN; Perumal M; Wares F; Narayanan PR
Int J Tuberc Lung Dis; 2006 Jan; 10(1):52-7. PubMed ID: 16466037
[TBL] [Abstract][Full Text] [Related]
7. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
[TBL] [Abstract][Full Text] [Related]
8. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
[TBL] [Abstract][Full Text] [Related]
9. Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi.
Harries AD; Michongwe J; Nyirenda TE; Kemp JR; Squire SB; Ramsay AR; Godfrey-Faussett P; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Feb; 8(2):204-10. PubMed ID: 15139449
[TBL] [Abstract][Full Text] [Related]
10. The diagnosis of smear-negative pulmonary tuberculosis: the practice of sputum smear examination in Malawi.
Harries AD; Nyirenda TE; Banerjee A; Boeree MJ; Salaniponi FM
Int J Tuberc Lung Dis; 1999 Oct; 3(10):896-900. PubMed ID: 10524587
[TBL] [Abstract][Full Text] [Related]
11. Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.
Harries AD; Gausi F; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Jun; 8(6):724-9. PubMed ID: 15182142
[TBL] [Abstract][Full Text] [Related]
12. Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes.
Harries AD; Hargreaves NJ; Graham SM; Mwansambo C; Kazembe P; Broadhead RL; Maher D; Salaniponi FM
Int J Tuberc Lung Dis; 2002 May; 6(5):424-31. PubMed ID: 12019918
[TBL] [Abstract][Full Text] [Related]
13. Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens.
Van Deun A; Aung KJ; Chowdhury S; Saha S; Pankaj A; Ashraf A; Rigouts L; Fissette K; Portaels F
Int J Tuberc Lung Dis; 1999 Feb; 3(2):143-8. PubMed ID: 10091880
[TBL] [Abstract][Full Text] [Related]
14. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
[TBL] [Abstract][Full Text] [Related]
15. Recurrent tuberculosis: definitions and treatment regimens.
Harries AD; Hargreaves NJ; Kwanjana JH; Salaniponi FM
Int J Tuberc Lung Dis; 1999 Oct; 3(10):851-4. PubMed ID: 10524580
[TBL] [Abstract][Full Text] [Related]
16. True status of smear-positive pulmonary tuberculosis defaulters in Malawi.
Kruyt ML; Kruyt ND; Boeree MJ; Harries AD; Salaniponi FM; van Noord PA
Bull World Health Organ; 1999; 77(5):386-91. PubMed ID: 10361755
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
Sevim T; Ataç G; Güngör G; Törün I; Aksoy E; Gemci ; Tahaoglu K
Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
[TBL] [Abstract][Full Text] [Related]
20. High early death rate in tuberculosis patients in Malawi.
Harries AD; Hargreaves NJ; Gausi F; Kwanjana JH; Salaniponi FM
Int J Tuberc Lung Dis; 2001 Nov; 5(11):1000-5. PubMed ID: 11716335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
